Literature DB >> 18679604

Effects and potential mechanisms of Danzhi Xiaoyao Pill on proliferation of MCF-7 human breast cancer cells in vitro.

Hui Liao1, Linda K Banbury, David N Leach.   

Abstract

OBJECTIVE: To investigate the effects of 50% ethyl alcohol (EtOH) extracts from Danzhi Xiaoyao Pill (, DXP) on the proliferation of MCF-7 human breast cancer cells and potential mechanisms.
METHODS: ATP-Lite assay was performed to test the proliferation of the MCF-7 breast cancer cell line; and antioxidant activity was measured by the oxygen radical absorbance capacity (ORAC). The effects of DXP on nitric oxide (NO) production were tested by lipopolysaccharide (LPS)-stimulated RAW 264.7 murine macrophages using the Griess reaction.
RESULTS: The 50% EtOH DXP extracts displayed a cytotoxic response on MCF-7 cells at 0.10, 0.25 and 0.50 mg/mL dose-dependently with the proliferation inhibited by more than 85%. The ORAC value of the DXP was 820 micro moL Trolox equivalent/g, about 40% of the vitamin C value. DXP extracts had significant inhibitory effect on NO production at the concentration from 0.0625 mg/mL to 0.5 mg/mL (P<0.05, P<0.01).
CONCLUSION: The extracts of DXP could significantly inhibit the proliferation of MCF-7 cells, with the effect possibly related to its antioxidant activity and the inhibition of NO production.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18679604     DOI: 10.1007/s11655-008-0128-y

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  11 in total

1.  Antiproliferative activity of Chinese medicinal herbs on breast cancer cells in vitro.

Authors:  Michael J Campbell; Bobbi Hamilton; Mark Shoemaker; Mary Tagliaferri; Isaac Cohen; Debasish Tripathy
Journal:  Anticancer Res       Date:  2002 Nov-Dec       Impact factor: 2.480

2.  Inhibitory effects of anthocyanins and other phenolic compounds on nitric oxide production in LPS/IFN-gamma-activated RAW 264.7 macrophages.

Authors:  J Wang; G Mazza
Journal:  J Agric Food Chem       Date:  2002-02-13       Impact factor: 5.279

3.  Viral mutation accelerated by nitric oxide production during infection in vivo.

Authors:  T Akaike; S Fujii; A Kato; J Yoshitake; Y Miyamoto; T Sawa; S Okamoto; M Suga; M Asakawa; Y Nagai; H Maeda
Journal:  FASEB J       Date:  2000-07       Impact factor: 5.191

4.  Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids.

Authors:  L C Green; D A Wagner; J Glogowski; P L Skipper; J S Wishnok; S R Tannenbaum
Journal:  Anal Biochem       Date:  1982-10       Impact factor: 3.365

Review 5.  Complementary and alternative medicine use among women with breast cancer.

Authors:  S R Adler
Journal:  Med Anthropol Q       Date:  1999-06

Review 6.  Role of nitric oxide in tumour progression with special reference to a murine breast cancer model.

Authors:  Lorraine C Jadeski; Chandan Chakraborty; Peeyush K Lala
Journal:  Can J Physiol Pharmacol       Date:  2002-02       Impact factor: 2.273

Review 7.  Nitric oxide and oxygen radicals in infection, inflammation, and cancer.

Authors:  H Maeda; T Akaike
Journal:  Biochemistry (Mosc)       Date:  1998-07       Impact factor: 2.487

8.  Comparison of antioxidant activity in commercial Ginkgo biloba preparations.

Authors:  David Mantle; Richard M Wilkins; Muhamed Asim Gok
Journal:  J Altern Complement Med       Date:  2003-10       Impact factor: 2.579

Review 9.  Anti-tumor promoting potential of selected spice ingredients with antioxidative and anti-inflammatory activities: a short review.

Authors:  Young-Joon Surh
Journal:  Food Chem Toxicol       Date:  2002-08       Impact factor: 6.023

10.  Use of complementary/alternative therapies by women with advanced-stage breast cancer.

Authors:  Joannie Shen; Ronald Andersen; Paul S Albert; Neil Wenger; John Glaspy; Melissa Cole; Paul Shekelle
Journal:  BMC Complement Altern Med       Date:  2002-08-13       Impact factor: 3.659

View more
  2 in total

1.  Exploration of the Molecular Mechanism of Danzhi Xiaoyao Powder in Endometrial Cancer through Network Pharmacology.

Authors:  Lanyu Li; Lukai Yang; Fang Liu; Jinfeng Qu
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-13       Impact factor: 2.650

2.  Exploring the Pharmacological Mechanism of Danzhi Xiaoyao Powder on ER-Positive Breast Cancer by a Network Pharmacology Approach.

Authors:  Kailin Yang; Liuting Zeng; Jinwen Ge
Journal:  Evid Based Complement Alternat Med       Date:  2018-03-05       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.